This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://localhost/temp/predkladatel/
n5http://linked.opendata.cz/resource/domain/vavai/projekt/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n21http://linked.opendata.cz/resource/domain/vavai/subjekt/
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11150%2F11%3A10099386%21RIV12-MZ0-11150___/
n20http://linked.opendata.cz/ontology/domain/vavai/
n16http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n6http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n19http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n22http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n14http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11150%2F11%3A10099386%21RIV12-MZ0-11150___
rdf:type
n20:Vysledek skos:Concept
rdfs:seeAlso
http://www.springerlink.com/content/m7w3515v97175162/fulltext.pdf
dcterms:description
Ischemia-modified albumin (IMA) is a laboratory biomarker of cardiac ischemia. Our study aims to determine whether IMA can estimate or represent to any degree the extent of myocardial ischemia. We expect that the higher the marker of cardiac necrosis (maximum value after serial measurements) the greater the preceding cardiac ischemia, indicated by IMA in patients diagnosed with STEMI prior to direct percutaneous coronary intervention (PCI). We studied 216 patients indicated for direct PCI with a diagnosis of ST elevation myocardial infarction.We observed that there was no significant association between increase in IMA and CK-MB (R2 = 0.011, p = 0.637). Similar results were noted in the case of cardiac troponin T (cTnT) (R2 = 0.0068, p = 0.483). We concluded that IMA does not provede information regarding the extent and scope of cardiac ischemia in patients with STEMI. Ischemia-modified albumin (IMA) is a laboratory biomarker of cardiac ischemia. Our study aims to determine whether IMA can estimate or represent to any degree the extent of myocardial ischemia. We expect that the higher the marker of cardiac necrosis (maximum value after serial measurements) the greater the preceding cardiac ischemia, indicated by IMA in patients diagnosed with STEMI prior to direct percutaneous coronary intervention (PCI). We studied 216 patients indicated for direct PCI with a diagnosis of ST elevation myocardial infarction.We observed that there was no significant association between increase in IMA and CK-MB (R2 = 0.011, p = 0.637). Similar results were noted in the case of cardiac troponin T (cTnT) (R2 = 0.0068, p = 0.483). We concluded that IMA does not provede information regarding the extent and scope of cardiac ischemia in patients with STEMI.
dcterms:title
Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction
skos:prefLabel
Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction
skos:notation
RIV/00216208:11150/11:10099386!RIV12-MZ0-11150___
n20:predkladatel
n21:orjk%3A11150
n3:aktivita
n19:Z n19:P
n3:aktivity
P(NR9174), Z(MZ0FNHK2005)
n3:cisloPeriodika
6
n3:dodaniDat
n14:2012
n3:domaciTvurceVysledku
n4:2398559 n4:6770401 n4:5889871 n4:8055165
n3:druhVysledku
n22:J
n3:duvernostUdaju
n18:S
n3:entitaPredkladatele
n13:predkladatel
n3:idSjednocenehoVysledku
227464
n3:idVysledku
RIV/00216208:11150/11:10099386
n3:jazykVysledku
n8:eng
n3:klicovaSlova
myocardial infarction; ischemia modified albumin (IMA)
n3:klicoveSlovo
n7:myocardial%20infarction n7:ischemia%20modified%20albumin%20%28IMA%29
n3:kodStatuVydavatele
DE - Spolková republika Německo
n3:kontrolniKodProRIV
[48D01CA0AF2D]
n3:nazevZdroje
Heart and Vessels
n3:obor
n15:FA
n3:pocetDomacichTvurcuVysledku
4
n3:pocetTvurcuVysledku
9
n3:projekt
n5:NR9174
n3:rokUplatneniVysledku
n14:2011
n3:svazekPeriodika
26
n3:tvurceVysledku
Dušek, Jaroslav Tichý, Miloš Chek, James Bukač, Josef Tomko, Tomáš Šťásek, Josef Vojáček, Jan Ulrychová, Martina Bis, Josef
n3:wos
000297175700009
n3:zamer
n16:MZ0FNHK2005
s:issn
0910-8327
s:numberOfPages
6
n6:doi
10.1007/s00380-010-0114-0
n17:organizacniJednotka
11150